Robert M. Anglin serves as Executive at ROCHESTER MEDICAL CORPORATION, where they oversee executive responsibilities. Since joining the company, Robert M. Anglin has executed 8 insider transactions totaling $129.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 14, 2013 involved selling 21,157 shares valued at $423.1K.
Robert M. Anglin currently holds 21,157 shares of ROCHESTER MEDICAL CORPORATION (ROCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert M. Anglin has been a net seller of ROCM stock. They have purchased $0 and sold $129.7K worth of shares.
Robert M. Anglin's most recent insider trade was on Nov 14, 2013, when they sold 21,157 shares at $20.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 1, 2013 | ROCM | $18.5K | Option Exercise | 4,000 | $4.63 | Discretionary |
| Mar 1, 2013 | ROCM | $58.8K | Sale | 4,000 | $14.70 | Discretionary |
| Jul 1, 2011 | ROCM | $17.4K | Option Exercise | 8,000 | $2.17 | Discretionary |
| Feb 7, 2011 | ROCM | $4.7K | Option Exercise | 2,000 | $2.34 | Discretionary |
| Sep 7, 2010 | ROCM | $70.9K | Sale | 8,000 | $8.86 | Discretionary |
| Sep 7, 2010 | ROCM | $18.7K | Option Exercise | 8,000 | $2.34 | Discretionary |